Automated Multiplex CRISPR-Cas12m (CasMicro) Vector Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic sub-400 amino acid ultra-compact Cas12m (CasMicro) non-viral synthetic lipid nanoparticle (LNP) packaging cleanroom suites, $600/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

CasMicro Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP CasMicro Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation